Zenith Tecnica expands EBM capacity with two new systems after acquisition by ex-Boeing, Amazon executives

New Zealand contract manufacturer Zenith Tecnica has been acquired by former Boeing and Amazon executives Andrew Burgess and Blair Jordan, with the deal closing on June 18, 2026. The new owners are immediately adding two additional Arcam EBM systems to the company's existing six-machine fleet and moving to a larger facility to address full-capacity utilization. Incoming Managing Director Blair Jordan stated the goal is scaling alongside customers while preserving the speed and flexibility that built Zenith's reputation. The company specializes in Electron Beam Melting (EBM) of titanium parts for space, medical orthopedics, and high-performance marine applications, with customers including Lanteris Space Systems for NASA's Psyche mission.

This acquisition fits the recurring pattern of specialized service bureaus reaching an operational ceiling and requiring capital and operational expertise to break through. Zenith Tecnica had maxed out its six EBM systems, a common bottleneck for contract manufacturers serving aerospace and medical verticals where qualification cycles are long but production volumes are steady once locked in. The incoming owners bring relevant scaling experience from Boeing's aerospace production lines and Amazon's low-earth orbit satellite programs, suggesting they understand the qualification grind and program-duration lock-in that define aerospace AM service economics. The expansion also underscores that EBM remains a distinct process niche within metal AM - valued for its low residual stress and high productivity in titanium, but limited by a smaller equipment installed base compared to LPBF. New Zealand's geographic isolation makes local service capacity particularly valuable for customers like NASA missions that cannot tolerate supply chain delays.

For Zenith Tecnica, the immediate execution challenge is integrating two new EBM systems without disrupting existing customer commitments - a non-trivial task given the qualification documentation tied to each machine. The move to a larger facility suggests they are betting on sustained demand from space and medical programs rather than diversifying into new processes. For buyers evaluating EBM service partners, this signals that Zenith intends to remain a dedicated EBM specialist rather than becoming a multi-process bureau, which may be an advantage for customers who value process depth over breadth.